Dankang BioHealth: Lab Test Results
Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Dankang BioHealth.
82
CoAs on file
99.15%
Avg reported purity
10
Compounds tested
Sep 2, 2026
Latest test
Results by compound
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 32 | 99.59% | Jul 19, 2026 |
| Tirzepatide | 10 | 99.86% | Jun 16, 2026 |
| Tesamorelin | 9 | 99.59% | May 26, 2026 |
| BPC-157 | 7 | 99.74% | Sep 2, 2026 |
| GHK-Cu | 7 | 99.81% | Jun 30, 2026 |
| MOTS-c | 6 | 98.82% | Jun 30, 2026 |
| NAD+ | 6 | 98.53% | May 5, 2026 |
| TB-500 | 3 | 98.3% | Jun 30, 2026 |
| TB-500 Thymosin Beta-4 | 1 | 99.6% | May 31, 2026 |
| TB-500 Fragment 17-23 | 1 | 76.75% | Jan 18, 2026 |
Recent CoAs
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| BPC-157 | n/a | 99.99% | Lab N | Sep 2, 2026 | verify |
| BPC-157 | vDK3707202605 | 99.3% | Lab E | Jul 19, 2026 | verify |
| Retatrutide | DK3707202605 | 99.8% | Lab E | Jul 19, 2026 | verify |
| TB-500 | n/a | n/a | Lab E | Jun 30, 2026 | verify |
| BPC-157 | n/a | n/a | Lab E | Jun 30, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | Jun 30, 2026 | verify |
| MOTS-c | n/a | 98.7% | Lab E | Jun 30, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jun 23, 2026 | verify |
| Retatrutide | n/a | n/a | Lab G | Jun 16, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab G | Jun 16, 2026 | verify |
| TB-500 Thymosin Beta-4 | DK3707202602 | 99.6% | Lab E | May 31, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | May 31, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | May 31, 2026 | verify |
| Tesamorelin | n/a | 99.7% | Lab E | May 26, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | May 26, 2026 | verify |
| TB-500 | n/a | n/a | Lab E | May 26, 2026 | verify |
| BPC-157 | n/a | 99.9% | Lab E | May 26, 2026 | verify |
| Retatrutide | n/a | 99.6% | Lab G | May 24, 2026 | verify |
| Retatrutide | n/a | n/a | Lab G | May 14, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | May 7, 2026 | verify |
| Retatrutide | 02/2026 | 94.9% | Lab E | May 7, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab E | May 5, 2026 | verify |
| Tesamorelin | n/a | 99.9% | Lab E | May 5, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | May 5, 2026 | verify |
| NAD+ | n/a | 95.9% | Lab E | May 5, 2026 | verify |
Showing 25 most recent of 82. Search the full database on the CoA page.
Embed this badge
Sell or represent Dankang BioHealth? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/dankang-biohealth/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/dankang-biohealth.svg" alt="Dankang BioHealth: lab tested, 82 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.